ACS Sensors,
Journal Year:
2023,
Volume and Issue:
8(10), P. 3623 - 3642
Published: Oct. 11, 2023
Over
the
past
few
decades,
pathogens
have
posed
a
threat
to
human
security,
and
rapid
identification
of
should
be
one
ideal
methods
prevent
major
public
health
security
outbreaks.
Therefore,
there
is
an
urgent
need
for
highly
sensitive
specific
approaches
identify
quantify
pathogens.
Clustered
Regularly
Interspaced
Short
Palindromic
Repeats
CRISPR/Cas
systems
Argonaute
(Ago)
belong
Microbial
Defense
Systems
(MDS).
The
guided,
programmable,
targeted
activation
nucleases
by
both
them
leading
way
new
generation
detection.
We
compare
these
two
in
terms
similarities
differences.
In
addition,
we
discuss
future
challenges
prospects
development
biosensors,
especially
electrochemical
biosensors.
This
review
expected
afford
researchers
entering
this
multidisciplinary
field
useful
guidance
provide
inspiration
more
innovative
biosensors
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(11), P. 9694 - 9747
Published: May 23, 2023
Two-dimensional
(2D)
material
research
is
rapidly
evolving
to
broaden
the
spectrum
of
emergent
2D
systems.
Here,
we
review
recent
advances
in
theory,
synthesis,
characterization,
device,
and
quantum
physics
materials
their
heterostructures.
First,
shed
insight
into
modeling
defects
intercalants,
focusing
on
formation
pathways
strategic
functionalities.
We
also
machine
learning
for
synthesis
sensing
applications
materials.
In
addition,
highlight
important
development
processing,
characterization
various
(e.g.,
MXnenes,
magnetic
compounds,
epitaxial
layers,
low-symmetry
crystals,
etc.)
discuss
oxidation
strain
gradient
engineering
Next,
optical
phonon
properties
controlled
by
inhomogeneity
give
examples
multidimensional
imaging
biosensing
equipped
with
analysis
based
platforms.
then
provide
updates
mix-dimensional
heterostructures
using
building
blocks
next-generation
logic/memory
devices
anomalous
Hall
high-quality
topological
insulators,
followed
small
twist-angle
homojunctions
exciting
transport.
Finally,
perspectives
future
work
several
topics
mentioned
this
review.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Oct. 29, 2022
Abstract
Fast,
inexpensive,
and
multiplexed
detection
of
multiple
nucleic
acids
is
great
importance
to
human
health,
yet
it
still
represents
a
significant
challenge.
Herein,
we
propose
acid
testing
platform,
named
MiCaR,
which
couples
mi
crofluidic
device
with
CRISPR-
C
as12a
nd
multiplex
r
ecombinase
polymerase
amplification.
With
only
one
fluorescence
probe,
MiCaR
can
simultaneously
test
up
30
targets
through
microfluidic
space
coding.
The
limit
achieves
0.26
attomole,
the
assay
takes
40
min.
We
demonstrate
utility
by
efficiently
detecting
nine
HPV
subtypes
targeted
9-valent
vaccine,
showing
sensitivity
97.8%
specificity
98.1%
in
100
patient
samples
at
risk
for
infection.
Additionally,
also
show
generalizability
our
approach
successfully
eight
most
clinically
relevant
respiratory
viruses.
anticipate
this
effective,
undecorated
versatile
platform
be
widely
used
detection.
ACS Infectious Diseases,
Journal Year:
2022,
Volume and Issue:
8(9), P. 1758 - 1814
Published: Aug. 8, 2022
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
a
highly
transmissible
and
virulent
human-infecting
that
emerged
in
late
December
2019
Wuhan,
China,
causing
disease
called
(COVID-19),
which
has
massively
impacted
global
public
health
caused
widespread
disruption
to
daily
life.
The
crisis
by
COVID-19
mobilized
scientists
authorities
across
the
world
rapidly
improve
our
knowledge
about
this
devastating
disease,
shedding
light
on
its
management
control,
spawned
development
of
new
countermeasures.
Here
we
provide
an
overview
state
art
gained
last
years
virus
COVID-19,
including
origin
natural
reservoir
hosts,
viral
etiology,
epidemiology,
modes
transmission,
clinical
manifestations,
pathophysiology,
diagnosis,
treatment,
prevention,
emerging
variants,
vaccines,
highlighting
important
differences
from
previously
known
pathogenic
coronaviruses.
We
also
discuss
selected
key
discoveries
each
topic
underline
gaps
for
future
investigations.
Nature Nanotechnology,
Journal Year:
2023,
Volume and Issue:
18(7), P. 798 - 807
Published: April 24, 2023
Synthetic
biomarkers,
bioengineered
sensors
that
generate
molecular
reporters
in
diseased
microenvironments,
represent
an
emerging
paradigm
precision
diagnostics.
Despite
the
utility
of
DNA
barcodes
as
a
multiplexing
tool,
their
susceptibility
to
nucleases
vivo
has
limited
utility.
Here
we
exploit
chemically
stabilized
nucleic
acids
multiplex
synthetic
biomarkers
and
produce
diagnostic
signals
biofluids
can
be
'read
out'
via
CRISPR
nucleases.
The
strategy
relies
on
microenvironmental
endopeptidase
trigger
release
acid
polymerase-amplification-free,
CRISPR-Cas-mediated
barcode
detection
unprocessed
urine.
Our
data
suggest
DNA-encoded
nanosensors
non-invasively
detect
differentiate
disease
states
transplanted
autochthonous
murine
cancer
models.
We
also
demonstrate
CRISPR-Cas
amplification
harnessed
convert
readout
point-of-care
paper
tool.
Finally,
employ
microfluidic
platform
for
densely
multiplexed,
CRISPR-mediated
potentially
evaluate
complex
human
diseases
rapidly
guide
therapeutic
decisions.
Analytical Chemistry,
Journal Year:
2023,
Volume and Issue:
95(6), P. 3379 - 3389
Published: Feb. 3, 2023
Timely
identification
of
human
papillomavirus
(HPV)
infection
is
crucial
for
the
prevention
cervical
cancer.
Current
HPV
detection
methods
mainly
rely
on
polymerase
chain
reaction
(PCR),
which
often
requires
bulky
equipment
and
a
long
assay
time.
In
this
work,
we
report
heating-membrane-assisted
multiplexed
microfluidics
platform
that
couples
recombinase
amplification
(RPA)
CRISPR
technology
(termed
M3-CRISPR)
fast
low-cost
multiple
subtypes.
The
heating
membrane
can
provide
convenient
temperature
control
on-chip
RPA
assays.
This
stand-alone
system
allows
simultaneous
HPV16
HPV18
with
high
specificity
sensitivity
(0.5
nM
1
×
10–18
M
unamplified
amplified
plasmids,
respectively)
in
30
min
fluorescence-based
readout.
Furthermore,
introduced
an
optimized
lateral
flow
dipstick
(LFD)
into
portable
to
allow
visualized
DNA.
LFD-based
readout
also
reached
plasmids
realized
successful
subtypes
clinical
samples.
Finally,
established
automatic
microfluidic
enables
sample-in-answer-out
We
believe
fast,
convenient,
affordable
molecular
diagnostic
serve
as
useful
tool
point-of-care
testing
or
other
pathogens.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(14), P. 13700 - 13714
Published: July 17, 2023
Digital
immunoassays
with
multiplexed
capacity,
ultrahigh
sensitivity,
and
broad
affordability
are
urgently
required
in
clinical
diagnosis,
food
safety,
environmental
monitoring.
In
this
work,
a
multidimensional
digital
immunoassay
has
been
developed
through
microparticle-based
encoding
artificial
intelligence-based
decoding,
enabling
detection
high
sensitivity
convenient
operation.
The
information
encoded
the
features
of
microspheres,
including
their
size,
number,
color,
allows
for
simultaneous
identification
accurate
quantification
multiple
targets.
Computer
vision-based
intelligence
can
analyze
microscopy
images
decoding
output
results
visually.
Moreover,
optical
imaging
be
well
integrated
microfluidic
platform,
allowing
encoding-decoding
computer
intelligence.
This
simultaneously
inflammatory
markers
antibiotics
within
30
min
range
from
pg/mL
to
μg/mL,
which
holds
great
promise
as
an
intelligent
bioassay
next-generation
biosensing.
Analytical Chemistry,
Journal Year:
2023,
Volume and Issue:
95(6), P. 3476 - 3485
Published: Feb. 1, 2023
Fast,
simplified,
and
multiplexed
detection
of
human
papillomaviruses
(HPVs)
is
great
importance
for
both
clinical
management
population
screening.
However,
current
HPV
methods
often
require
sophisticated
instruments
laborious
procedures
to
detect
multiple
targets.
In
this
work,
we
developed
a
simple
microfluidic
dual-droplet
device
(M-D3)
the
simultaneous
HPV16
HPV18
by
combining
CRISPR-Cas12a
system
recombinase
polymerase
amplification
(RPA)
assay.
A
new
approach
pressure/vacuum
was
proposed
efficient
droplet
generation
with
minimal
sample
consumption.
Two
groups
droplets
that
separately
encapsulate
relevant
Cas12a/crRNA
fluorescent
green
or
red
reporters
are
parallelly
generated,
followed
automatic
imaging
discriminate
subtypes
based
on
specific
fluorescence
droplets.
The
M-D3
platform
performs
high
sensitivity
(∼0.02
nM
unamplified
plasmids)
specificity
in
detecting
DNA.
By
RPA
Cas12a
assay,
allows
on-chip
DNA
simultaneously
within
30
min,
reaching
limit
10–18
M
(∼1
copy/reaction).
Moreover,
outstanding
performance
validated
testing
20
patient
samples
infection
risk,
showing
92.3%
100%.
integrating
generator,
CRISPR-Cas12a,
RPA,
provides
an
way
two
most
harmful
holds
potential
applications
nucleic
acid
testing.
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
63(20)
Published: March 22, 2024
Abstract
The
CRISPR‐Cas12a
system
has
emerged
as
a
powerful
tool
for
next‐generation
nucleic
acid‐based
molecular
diagnostics.
However,
it
long
been
believed
to
be
effective
only
on
DNA
targets.
Here,
we
investigate
the
intrinsic
RNA‐enabled
trans‐
cleavage
activity
of
AsCas12a
and
LbCas12a
discover
that
they
can
directly
activated
by
full‐size
RNA
targets,
although
exhibits
weaker
than
both
single‐stranded
substrates.
Remarkably,
find
RNA‐activated
Cas12a
possesses
higher
specificity
in
recognizing
mutated
target
sequences
compared
activation.
Based
these
findings,
develop
“
U
niversal
N
uclease
I
dentification
V
irus
E
mpowered
R
NA‐
Se
nsing”
(UNIVERSE)
assay
acid
testing.
We
incorporate
T7
transcription
step
into
this
assay,
thereby
eliminating
requirement
protospacer
adjacent
motif
(PAM)
sequence
target.
Additionally,
successfully
detect
multiple
PAM‐less
targets
HIV
clinical
samples
are
undetectable
conventional
based
double‐stranded
activation,
demonstrating
unrestricted
selection
with
UNIVERSE
assay.
further
validate
utility
testing
HPV
16
samples.
envision
targeting
capability
may
bring
paradigm
shift
Cas12a‐based
detection
enhance
understanding
CRISPR‐Cas
biochemistry.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 2, 2024
Abstract
Real-time
and
continuous
monitoring
of
nucleic
acid
biomarkers
with
wearable
devices
holds
potential
for
personal
health
management,
especially
in
the
context
pandemic
surveillance
or
intensive
care
unit
disease.
However,
achieving
high
sensitivity
long-term
stability
remains
challenging.
Here,
we
report
a
tetrahedral
nanostructure-based
Natronobacterium
gregoryi
Argonaute
(NgAgo)
stable
ultratrace
unamplified
acids
(cell-free
DNAs
RNAs)
vivo
sepsis
on
device.
This
integrated
wireless
consists
flexible
circuit
board,
microneedle
biosensor,
stretchable
epidermis
patch
enrichment
capability.
We
comprehensively
investigate
recognition
mechanism
by
NgAgo/guide
DNA
signal
transformation
within
Debye
distance.
In
experiments
demonstrate
suitability
real-time
cell-free
RNA
0.3
fM
up
to
14
days.
These
results
provide
strategy
highly
sensitive
molecular
on-body
detection
acid.